Active Ingredient History
Tivozanib, sold under the brand name Fotivda, is a medication used for the treatment of advanced renal cell carcinoma. It is an oral VEGF receptor tyrosine kinase inhibitor. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Carcinoma, Renal Cell (approved 2021)
Adenocarcinoma of Lung (Phase 2)
Anemia (Phase 2)
Bile Duct Neoplasms (Phase 1/Phase 2)
Biliary Tract Neoplasms (Phase 1/Phase 2)
Breast Diseases (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma, Hepatocellular (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Cholangiocarcinoma (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 2)
Epidermal Growth Factor (Phase 1/Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Gallbladder Neoplasms (Phase 1/Phase 2)
Gastrointestinal Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 1)
Healthy Volunteers (Phase 1)
Liver Diseases (Phase 1)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Macular Degeneration (Phase 2)
Macular Edema (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms ()
Neuroendocrine Tumors (Phase 1/Phase 2)
Neutropenia (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Pharmacology (Phase 1)
Prostatic Neoplasms (Phase 2)
Sarcoma (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Vulvar Neoplasms (Phase 1/Phase 2)
Wet Macular Degeneration (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue